ÂÜÀòÂÒÂ×

Elizabeth Brouwer, PhD, has a diverse work experience in health economics and outcomes research. Elizabeth currently works as an Associate Director at Curta, where they collaborate with biopharmaceutical companies on various projects involving health economics and outcomes research. Elizabeth'sresponsibilities include developing evidence-based value stories and communication tools for emerging therapies, devices, and tests. Elizabeth specializes in real-world data and evidence generation using claims data and electronic health records. Additionally, they contribute to budget impact models, cost-effectiveness models, systematic literature reviews/meta-analyses, and payer communication tools.

Prior to their current role, Dr. Brouwer served as a Research Engineer at the University of Washington, where they developed economic models under contract with the Institute for Clinical and Economic Review. Elizabeth was involved in building models and writing economics sections for reports on Atopic Dermatitis and T2DM, and provided support for model building in Multiple Myeloma and Multiple Sclerosis. Elizabeth also worked as a PhD Candidate and later a PhD Student at the University of Washington, CHOICE Institute, where they focused on coursework in biostatistics, statistical programming, epidemiology, econometrics, and policy analysis. Elizabeth conducted research on value-based frameworks, cost-effectiveness analysis, and health economics methodology.

In addition to their academic experience, Dr. Brouwer has worked as a Research Analyst at Kaiser Permanente Washington Health Research Institute, exploring the effects of value-based formulary tiering within value-based insurance design. Elizabeth also served as a Contract Research Analyst at the Institute for Clinical and Economic Review, where they assisted in building markov models to assess the added value of new pharmaceutical therapies compared to existing therapies.

Furthermore, they have interned as a Health Economics Intern at PATH, where they worked on a cost analysis of novel contraceptive technology in sub-Saharan Africa, and as a Research Consultant at RTI International, focusing on the NCD investment case for Mongolia in collaboration with the United Nations NCD Task Force and the World Health Organization. Dr. Brouwer has also contributed extensively to health economics research and capacity building through their role as a Health Economics Analyst at Disease Control Priorities, where they conducted and supported research on health economics modeling, costing analysis, and cost-effectiveness analysis. Elizabeth organized and administrated workshops to enhance health economics research capacity in Nairobi, Kenya and Cairo, Egypt.

Before their professional positions, Dr. Brouwer was a student at the University of Michigan School of Public Health, where they received the School of Public Health's Dean's Research Award as a Research Assistant. Elizabeth'swork during this time involved using Stata and ArcGIS to analyze tuberculosis testing, treatment, and health utilization data in South Africa.

Overall, Elizabeth Brouwer, PhD, has a strong background in health economics and outcomes research, with expertise in real-world data analysis, economic modeling, systematic literature reviews, and cost-effectiveness analysis. Elizabeth'swork experience spans various academic and industry settings, demonstrating their versatility and dedication to advancing the field of health economics.

Elizabeth Brouwer, PhD, obtained their Bachelor of Arts (BA) degree from the University of Michigan in 2009. Elizabeth'sfield of study during their undergraduate years included Public Policy, French, and Political Science. Following their undergraduate studies, they pursued a Master's Degree in Health Economics at the University of Michigan from 2011 to 2013. Finally, Elizabeth completed their Doctor of Philosophy (Ph.D.) in Pharmacy, specializing in Health Economics and Outcomes Research, at the University of Washington from 2015 to 2019.